Acorda Therapeutics Inc (NASDAQ:ACOR)

23.55
Delayed Data
As of May 24
 +0.30 / +1.29%
Today’s Change
13.60
Today|||52-Week Range
29.60
+9.79%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Scopia Capital Management Lp
Buy8/29/2017500,000$19.05$9.5M+21.08%
Scopia Capital Management Lp
Buy8/29/2017150,000$19.52$2.9M+21.08%
Scopia Capital Management Lp
Buy8/29/2017116,201$19.62$2.3M+21.08%
Cohen Ronald
President & Chief Executive Officer
Buy3/05/201862,500$19.81$1.2M-9.25%
Wasman Jane
President-International & General Counsel
Sale1/19/201834,170$27.58$942.4K-13.42%
Lawrence David /acorda/
Sale1/19/201829,918$27.58$825.1K-13.42%
Wasman Jane
President-International & General Counsel
Buy1/19/201834,520$19.81$683.8K-13.42%
Cohen Ronald
President & Chief Executive Officer
Sale3/05/201824,590$25.95$638.1K-9.25%
Lawrence David /acorda/
Buy1/19/201830,418$19.81$602.6K-13.42%
Cohen Ronald
President & Chief Executive Officer
Buy6/16/201720,000$16.95$339.0K+36.52%
Page of 5